Li Caralynn, Amin Ushtar, Rivera-Cruz Angelica, Frontera Alfred T, Benbadis Selim R
Department of Neurology, University of South Florida Morsani College of Medicine.
Neurol Clin Pract. 2023 Oct;13(5):e200194. doi: 10.1212/CPJ.0000000000200194. Epub 2023 Sep 14.
The purpose of this study was to assess the likelihood of capturing a patient's typical event in question on ambulatory video-EEG monitoring (AVEM) based on certain baseline patient or event characteristics.
We retrospectively reviewed 300 studies that resulted between June 2021 and August 2022 ordered by adult epileptologists. Patients were included in event analysis if the study was ordered for the purpose of capturing an event (and excluded for all other purposes).
A total of 149 studies were included in event analysis. Sixty-eight patients (46%) had their typical events captured on AVEM. Diagnosis was an epileptic seizure in 17 patients (25%), psychogenic nonepileptic seizure in 7 (10%), and other nonepileptic events in 44 (65%). Regarding event frequency, for patients who on average had daily events, 84% had events captured, which corresponds to a significantly increased odds ratio (OR 17.90, 95% CI 7.55-42.44, < 0.001). For those who had events <1 per week to ≥1 per month, only 9% had events captured (OR 0.06, 95% CI 0.02-0.19, < 0.001). No patients who had events less frequently than once per month had a diagnostic AVEM. Regarding the number of antiseizure medications (ASMs), the odds ratio was increased for those not on ASMs (OR 2.65, 95% CI 1.17 -6.03, = 0.02) and decreased for those on 1 ASM (OR 0.28, 95% CI 0.13 -0.60, = 0.001). There was no statistical significance based on event type (motor vs nonmotor), prior seizure diagnosis, history of psychiatric comorbidity, or presence of a focal brain lesion.
Certain baseline characteristics can increase or decrease the pretest probability of capturing a typical event on AVEM, particularly the frequency of events and number of ASMs. This can be useful information for clinicians before ordering a study so that resources can be properly allocated.
本研究旨在根据患者或事件的某些基线特征,评估在动态视频脑电图监测(AVEM)中捕捉到患者所关注典型事件的可能性。
我们回顾性分析了2021年6月至2022年8月间由成人癫痫专家安排的300项研究。如果研究目的是捕捉某一事件,则将患者纳入事件分析(排除所有其他目的的研究)。
共有149项研究纳入事件分析。68例患者(46%)在AVEM中捕捉到了典型事件。诊断为癫痫发作的有17例(25%),精神性非癫痫发作的有7例(10%),其他非癫痫事件的有44例(65%)。关于事件频率,对于平均每天有发作事件的患者,84%的患者捕捉到了发作事件,这对应着显著增加的优势比(OR 17.90,95% CI 7.55 - 42.44,< 0.001)。对于那些发作事件每周少于1次至每月≥1次的患者,只有9%的患者捕捉到了发作事件(OR 0.06,95% CI 0.02 - 0.19,< 0.001)。每月发作事件少于1次的患者中,没有患者通过AVEM得到诊断。关于抗癫痫药物(ASM)的数量,未服用ASM的患者优势比增加(OR 2.65,95% CI 1.17 - 6.03,= 0.02),而服用1种ASM的患者优势比降低(OR 0.28,95% CI 0.13 - 0.60,= 0.001)。基于事件类型(运动性与非运动性)、既往癫痫诊断、精神疾病合并史或局灶性脑病变的存在情况,差异无统计学意义。
某些基线特征可增加或降低在AVEM中捕捉到典型事件的预测试概率,尤其是事件频率和ASM数量。这对于临床医生在安排检查前是有用的信息,以便能合理分配资源。